Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Egle

Showing results (41-50 of 107) with videos related to

Pageof 11
Sort By:
Plos One|July 8, 2017
Prognostic score in patients with recurrent or metastatic carcinoma of the head and neck treated with cetuximab and chemotherapyTeresa Magnes, Thomas Melchardt, Lukas Weiss, et al.
Geroscience|April 10, 2021
Results of a hospitalization policy of asymptomatic and pre-symptomatic COVID-19-positive long-term care facility residents in the province of Salzburg-a report from the AGMT COVID-19 RegistryFlorian Huemer, Gabriel Rinnerthaler, Benedikt Jörg, et al.
Blood|September 21, 2019
B-cell-specific IRF4 deletion accelerates chronic lymphocytic leukemia development by enhanced tumor immune evasionDaniela Asslaber, Yuan Qi, Nicole Maeding, et al.
Wiener Klinische Wochenschrift|January 21, 2014
Human immunodeficiency virus type 2 infections in AustriaNinon Taylor, Jan Marco Kern, Wolfgang Prammer, et al.
Leukemia|September 29, 2018
Exome sequencing of the TCL1 mouse model for CLL reveals genetic heterogeneity and dynamics during disease developmentNadja Zaborsky, Franz J Gassner, Jan P Höpner, et al.
Theranostics|May 4, 2018
DNA Methylation Signatures Predicting Bevacizumab Efficacy in Metastatic Breast CancerSimon Peter Gampenrieder, Gabriel Rinnerthaler, Hubert Hackl, et al.
BMC Cancer|October 18, 2015
CYP39A1 polymorphism is associated with toxicity during intensive induction chemotherapy in patients with advanced head and neck cancerThomas Melchardt, Clemens Hufnagl, Teresa Magnes, et al.
Oncology Letters|January 23, 2020
Evaluation of circulating cell-free DNA as a molecular monitoring tool in patients with metastatic cancerClemens Hufnagl, Michael Leisch, Lukas Weiss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 2018
BIRC3 Expression Predicts CLL Progression and Defines Treatment Sensitivity via Enhanced NF-κB Nuclear TranslocationDaniela Asslaber, Nathalie Wacht, Michael Leisch, et al.
Plos One|August 31, 2011
Differential bone marrow homing capacity of VLA-4 and CD38 high expressing chronic lymphocytic leukemia cellsGabriele Brachtl, Karine Sahakyan, Ursula Denk, et al.
Pageof 11

Showing results (41-50 of 107) with videos related to

Sort By:
Pageof 11
Plos One|July 8, 2017
Prognostic score in patients with recurrent or metastatic carcinoma of the head and neck treated with cetuximab and chemotherapyTeresa Magnes, Thomas Melchardt, Lukas Weiss, et al.
Geroscience|April 10, 2021
Results of a hospitalization policy of asymptomatic and pre-symptomatic COVID-19-positive long-term care facility residents in the province of Salzburg-a report from the AGMT COVID-19 RegistryFlorian Huemer, Gabriel Rinnerthaler, Benedikt Jörg, et al.
Blood|September 21, 2019
B-cell-specific IRF4 deletion accelerates chronic lymphocytic leukemia development by enhanced tumor immune evasionDaniela Asslaber, Yuan Qi, Nicole Maeding, et al.
Wiener Klinische Wochenschrift|January 21, 2014
Human immunodeficiency virus type 2 infections in AustriaNinon Taylor, Jan Marco Kern, Wolfgang Prammer, et al.
Leukemia|September 29, 2018
Exome sequencing of the TCL1 mouse model for CLL reveals genetic heterogeneity and dynamics during disease developmentNadja Zaborsky, Franz J Gassner, Jan P Höpner, et al.
Theranostics|May 4, 2018
DNA Methylation Signatures Predicting Bevacizumab Efficacy in Metastatic Breast CancerSimon Peter Gampenrieder, Gabriel Rinnerthaler, Hubert Hackl, et al.
BMC Cancer|October 18, 2015
CYP39A1 polymorphism is associated with toxicity during intensive induction chemotherapy in patients with advanced head and neck cancerThomas Melchardt, Clemens Hufnagl, Teresa Magnes, et al.
Oncology Letters|January 23, 2020
Evaluation of circulating cell-free DNA as a molecular monitoring tool in patients with metastatic cancerClemens Hufnagl, Michael Leisch, Lukas Weiss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 2018
BIRC3 Expression Predicts CLL Progression and Defines Treatment Sensitivity via Enhanced NF-κB Nuclear TranslocationDaniela Asslaber, Nathalie Wacht, Michael Leisch, et al.
Plos One|August 31, 2011
Differential bone marrow homing capacity of VLA-4 and CD38 high expressing chronic lymphocytic leukemia cellsGabriele Brachtl, Karine Sahakyan, Ursula Denk, et al.
Pageof 11